G9610 Documentation (HCPCS) Reimbursement & Policy

HCPCS Level II code G9610 denotes documentation in the medical record of the clinical reason(s) for not ordering anti-platelet agents. As a code focused on clinical justification and medical decision-making, G9610 supports care transparency, audit readiness, and payer review of medication management decisions. Nationally, standardized use of such documentation codes can affect quality measurement, utilization review, and claims adjudication processes.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise explanation of the code’s clinical intent and service context, guidance on common billing considerations, and an overview of where documentation intersects with payer policy and quality reporting. The publication summarizes typical sites of service where the code is applied, common modifier usage provided in the input, and notes on related administrative workflows.

This summary equips clinical coders, billing staff, compliance officers, and policy analysts with the information needed to recognize when G9610 applies, understand its role in supporting medication management decisions, and anticipate areas where documentation may be reviewed by payers or auditors. Data not available in the input is noted where relevant.

Billing Code Overview

HCPCS Level II code G9610 documents the medical reason(s) in the patient's record for not ordering anti-platelet agents. This code captures clinician documentation explaining why anti-platelet therapy was not prescribed when it might otherwise be considered.

Service type: Documentation/Medical Decision Support

Typical site of service: Inpatient and outpatient clinical settings where medication management and treatment justification are recorded, including hospitals, emergency departments, and ambulatory clinics.

Clinical Context

A typical patient scenario involves an adult admitted to an inpatient hospital setting after an acute ischemic stroke, transient ischemic attack (TIA), or acute coronary syndrome who otherwise would receive anti-platelet therapy but for documented contraindications. The treating physician evaluates the patient during admission or at the time of disposition and documents a clear medical reason in the chart for not ordering antiplatelet agents (for example, active major bleeding, recent intracranial hemorrhage, severe thrombocytopenia, need for imminent surgery with high bleeding risk, or documented allergy with anaphylaxis). The clinical workflow includes: initial assessment by the emergency department or stroke team; diagnostic imaging (CT/MRI) and laboratory evaluation (including platelet count and coagulation studies); multidisciplinary discussion (neurology, cardiology, hematology, or surgery as indicated); and explicit documentation in the medical record of the medical reason(s) for withholding antiplatelet therapy. This documentation supports use of billing code G9610 for quality reporting and payor review when anti-platelet agents are not ordered for eligible patients due to documented medical reasons.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased Procedural Services	Use when work required to document reasons for not ordering anti-platelet agents is substantially greater than typical (rare for documentation-only codes).

Taxonomy Code	Specialty	Notes
`207RH0000X`	Neurology	Neurologists commonly document reasons to withhold antiplatelet agents after stroke or intracranial hemorrhage risk assessment.
`207RC0000X`	Cardiology	Cardiologists document withholding antiplatelet therapy in acute coronary syndrome or periprocedural contexts.
`208000000X`	Internal Medicine	Hospitalists and internists document medical contraindications and coordinate multidisciplinary care.
`2085P0202X`	Critical Care Medicine	Intensivists document withholding antiplatelet agents in critically ill patients with bleeding risk.
`207LG0400X`	Vascular Surgery	Vascular surgeons document perioperative decisions to withhold antiplatelet agents for bleeding risk or procedural timing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I63.9`	Cerebral infarction, unspecified	Ischemic stroke where antiplatelet therapy is usually indicated unless contraindicated; documentation required if withheld.
`I61.9`	Intracerebral hemorrhage, unspecified	Active intracranial bleeding is a major contraindication to antiplatelet therapy; documentation for withholding is critical.
`D69.6`	Thrombocytopenia, unspecified	Severe thrombocytopenia increases bleeding risk and is a medical reason to avoid antiplatelet agents.
`K92.2`	Gastrointestinal hemorrhage, unspecified	Active GI bleeding is a contraindication to antiplatelet therapy and warrants documented rationale for withholding.
`T88.7XXA`	Unspecified adverse effect of drug, initial encounter	Documented severe allergic reaction to antiplatelet medication may justify not ordering agents.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99221`	Initial hospital inpatient care, typically 30 minutes at bedside	Often performed on admission when evaluation documents reasons to withhold antiplatelet therapy as part of the initial assessment.
`99231`	Subsequent hospital inpatient care, typically 15 minutes	Used for daily follow-up notes that may document ongoing reasons for not prescribing antiplatelet agents.
`99238`	Hospital discharge day management; 30 minutes	Discharge documentation often reiterates medical reasons for withholding antiplatelet therapy and informs outpatient plans.
`70450`	CT head without contrast	Performed to evaluate for intracranial hemorrhage, a common medical reason to withhold antiplatelet therapy.
`71020`	Chest x-ray, two views	May be obtained as part of pre-procedure or admission workup influencing bleeding risk and antiplatelet decisions.

OpenPayer

Summary & Overview

HCPCS G9610: Documentation of Reason for Not Ordering Anti-Platelet Agents